- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04264832
Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome
Department of Traditional Chinese Medicine (TCM), Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing 100191, China.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- Peking University Third Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18 to 45 years
- For the PCOS group, PCOS diagnosis according to Rotterdam criteria 2003 with at least two of the following three symptoms: (1) infrequent ovulation or anovulation; (2) hyperandrogenism or clinical manifestations of high blood androgen; (3) ultrasound findings of polycystic ovaries in 1 or 2 ovaries, or ≥12 follicles measuring 2 to 9 mm in diameter, and/or ovarian volume ≥10 mL
Exclusion Criteria:
- Exclusion of other endocrine disorders such as androgen secreting tumors, suspected Cushing's syndrome and non-classic congenital adrenal hyperplasia (17-hydroxyprogesterone < 3nmol/L) thyroid dysfunction and hyperprolactinemia.
- Type I diabetes or not well controlled type II diabetes
- Stage 2 hypertension (resting blood pressure ≥160/100mmHg)
- Psychiatric diagnoses or using psychiatric medications including antidepressants
- Pharmacological treatment (cortizone, antidepressant, other antidiabetic treatment such as insulin and acarbose, hormonal contraceptives, hormonal ovulation induction or other drugs judged by discretion of investigator) within 12 weeks. Depo Provera or similar within 6 months.
The control group are non- PCOS normal women (age 18-45) and meet the same exclusion criteria.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
observation group
Participants were eligible if they met the Rotterdam diagnostic criteria of polycystic ovary syndrome (PCOS) and meet the inclusion and exclusion criteria , and all study participants received questionnaires and underwent the physical, transvaginal ultrasound and body composition examination.
Blood samples were collected for analysis of metabolic markers, metabonomics and hormones.
|
Basic characteristics: Participants were carefully characterized with regard to a general health history, a medical history, clinical, demographic and anthropomorphic measurements, skin problems (hirsutism is modified by Ferriman-Gallwey (mF-G) score , global acne score and premature alopecia). A transvaginal ultrasound scan was performed on every participant during a clinical examination to determine the number of follicles and ovarian volume. Metabolic and other assessments: General gynecological examination, prolactin, thyroid, androgen, LH, FSH, DA, 5-HT, metabonomics, glucose, insulin, triglyceride (TG), LDL and HDL were determined, OGTT was performed. Questionnaires: The perceived stress scale(Chinese 14-item PSS), self-rating anxiety scale (SAS), self-rating depressive scale(SDS) were used to assess the participants' mental health status. The MOS item short from health survey (SF-36) was used to assess the quality of life . |
control group
The control group participants are normal women and had no history of any type of diabetes, cardiovascular disease (myocardial infarction, unstable angina, stroke or cardiovascular revascularization), stage 2 hypertension , malignant disease or severe renal or hepatic disease.
They accepted the same examinations as the observation group.
|
Basic characteristics: Participants were carefully characterized with regard to a general health history, a medical history, clinical, demographic and anthropomorphic measurements, skin problems (hirsutism is modified by Ferriman-Gallwey (mF-G) score , global acne score and premature alopecia). A transvaginal ultrasound scan was performed on every participant during a clinical examination to determine the number of follicles and ovarian volume. Metabolic and other assessments: General gynecological examination, prolactin, thyroid, androgen, LH, FSH, DA, 5-HT, metabonomics, glucose, insulin, triglyceride (TG), LDL and HDL were determined, OGTT was performed. Questionnaires: The perceived stress scale(Chinese 14-item PSS), self-rating anxiety scale (SAS), self-rating depressive scale(SDS) were used to assess the participants' mental health status. The MOS item short from health survey (SF-36) was used to assess the quality of life . |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
body fat content and ratio
Time Frame: Baseline
|
Examined with a body composition analyzer (Tanita Corporation, model MC-180, Japan)
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body mass index (BMI)
Time Frame: Baseline
|
Weight in kilograms divided by the square of height in meters, reported in kg/m2
|
Baseline
|
Waist circumference(WC)
Time Frame: Baseline
|
Waist circumference(WC)reported in cm, refers to the horizontal circumference along the midpoint of the connection line of the anterior superior iliac crest through the lower costal margin of the calm breathing state when standing.
Recumbent position is the abdominal circumference through the girth of the navel.
|
Baseline
|
Hip circumference
Time Frame: Baseline
|
Hip circumference reported in cm, and when measured, the legs are upright and closed together, the arms are naturally pendulous, and the tape measure is placed horizontally on the pubic symphysis in front and the gluteus maximus in the back.
|
Baseline
|
Waist-hip ratio (WHR)
Time Frame: Baseline
|
Waist-to-hip ratio
|
Baseline
|
Fat content and ratio of trunk
Time Frame: Baseline
|
Examined with a body composition analyzer (Tanita Corporation, model MC-180, Japan)
|
Baseline
|
Follicle stimulating hormone (FSH)
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
luteinizing hormone (LH)
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
Progestin (P)
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
Estrogen (E2)
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
Prolactin (PRL)
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
Androgen(T)
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
Androstenedione (A2)
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
Glucose
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
Insulin
Time Frame: Baseline
|
Examined with the blood sample
|
Baseline
|
HOMA-IR
Time Frame: Baseline
|
calculation of HOMA-IR: [fasting insulin (μU/mL) × fasting glucose (mmol/L)] / 22.5)
|
Baseline
|
HOMA- β
Time Frame: Baseline
|
calculation of HOMA-β: 20 × fasting insulin (mU/mL) / (fasting plasma glucose (mmol/L) - 3.5) (%)
|
Baseline
|
total cholesterol
Time Frame: Baseline
|
examined with the blood sample
|
Baseline
|
triglycerides
Time Frame: Baseline
|
examined with the blood sample
|
Baseline
|
high density lipoprotein (HDL)
Time Frame: Baseline
|
examined with the blood sample
|
Baseline
|
low density lipoprotein (LDL)
Time Frame: Baseline
|
examined with the blood sample examined with the blood sample
|
Baseline
|
β-endorphin
Time Frame: Baseline
|
examined with the blood sample
|
Baseline
|
5- hydroxytryptamine (5-HT)
Time Frame: Baseline
|
examined with the blood sample
|
Baseline
|
Dopamine(DA)
Time Frame: Baseline
|
examined with the blood sample
|
Baseline
|
lipometabonomics
Time Frame: Baseline
|
examined with the blood sample
|
Baseline
|
bile acid
Time Frame: Baseline
|
examined with the blood sample (fasting plasma glucose (mmol/L) - 3.5) (%)
|
Baseline
|
FerrimanGallwey (FG )value
Time Frame: Baseline
|
To determine changes in women's hairy with FG rating scale (0-36 score), the higher, the worse
|
Baseline
|
short form-36 (SF36)
Time Frame: Baseline
|
determine the health quality of life by the questionnaire of SF36 (0-100 score), the higher, the better
|
Baseline
|
Self-Rating Anxiety Scale (SAS)
Time Frame: Baseline
|
determine the anxiety level with the questionnaire of SAS (20-100 score), the higher, the worse.
|
Baseline
|
Self-Rating Depress Scale (SDS)
Time Frame: Baseline
|
determine the depress level with the questionnaire of SDS (20-100 score), the higher, the worse
|
Baseline
|
Preserved Stress Scale (PSS)
Time Frame: Baseline
|
determine the stress level with the questionnaire of SDS (14-56 score), the higher, the worse
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Haolin Zhang, Peking University Third Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Peking TCM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome (PCOS)
-
Cornell UniversityLaidlaw Foundation; Epperson Fund; Beck Fellowship; Dan Cane FundCompletedPolycystic Ovary Syndrome | Ovarian Cysts | PCOS | Dysmenorrhea | Menstrual Pain | Premenstrual Dysphoric Disorder | Premenstrual Syndrome | Period Pain | Menstrual Problem | PMS | Menstrual Discomfort | Dysmenorrhea Primary | Cramps | Menstrual Cycle Abnormal | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Period... and other conditionsUnited States
-
University of CopenhagenCompletedPolycystic Ovary Syndrome (PCOS)Denmark
-
Odense University HospitalCompleted
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Saudi German Hospital - MadinahCompletedPolycystic Ovary Syndrome (PCOS)Saudi Arabia
-
Poznan University of Medical SciencesUniversity of California, DavisUnknownPolycystic Ovary Syndrome (PCOS)Poland
-
Fundació Sant Joan de DéuRecruitingPolycystic Ovary Syndrome (PCOS)Norway, Austria, Denmark, Italy, Spain, Turkey
-
Riphah International UniversityCompleted
-
Dexa Medica GroupCompletedPolycystic Ovary Syndrome (PCOS)Indonesia
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedPolycystic Ovary Syndrome (PCOS)United States
Clinical Trials on Clinical data collection
-
Centre Hospitalier Universitaire DijonCompletedCoronary Artery Bypass Graft | Anomalies in Glucose MetabolismFrance
-
Corporacion Parc TauliRecruitingMechanical Ventilation Complication | Weaning FailureSpain
-
Institut Paoli-CalmettesRecruiting
-
Shanghai Zhongshan HospitalNot yet recruitingPreoperative Nutritional Status and Risk Factors Associated With Elderly Patients Undergoing Gastrectomy
-
Fadoi Foundation, ItalyUniversity of GenovaUnknown
-
National Institute of Allergy and Infectious Diseases...Boston Children's Hospital; Benaroya Research InstituteCompletedSARS-CoV-2 | Coronavirus Disease 2019 (COVID-19)United States
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingCerebrospinal; DisorderFrance
-
University Hospital, Basel, SwitzerlandCompletedPatellar InstabilitySwitzerland
-
Heinrich-Heine University, DuesseldorfRecruitingST-segment Elevation Myocardial Infarction (STEMI)Germany
-
Heinrich-Heine University, DuesseldorfRecruitingAortic Stenosis | Aortic Aneurysm | Aortic Disease | Large Artery StiffnessGermany